INTRODUCTION
A number of markers permit the prospective identification and isolation of hematopoietic stem cells (HSCs) and multipotent progenitors (MPPs) (Bryder et al., 2006) . In the adult mouse, all multipotent cells are contained in the Lineage À/low Sca-1 + c-Kit + (LSK) fraction of bone marrow cells, though this population is very heterogeneous (Spangrude et al., 1988; Ikuta and Weissman, 1992; Uchida et al., 1994) . Higher levels of HSC purity can be achieved by selecting the Thy-1 low subset of Lineage À/low Sca-1 + cells (Spangrude et al., 1988) , 1997) . Higher levels of HSC purity are also achieved by selecting the subset of LSK cells that is CD34 negative/low (Osawa et al., 1996) , Flt3 negative (Christensen and Weissman, 2001; Adolfsson et al., 2005; Yang et al., 2005) , or effluxes Hoechst 33342 (Goodell et al., 1996) . HSCs can also be isolated using the SLAM family markers CD150 (also known as Slamf1) and CD48 (Slamf2) as CD150 + CD48 À cells (Forsberg et al., 2005; Kiel et al., 2005 Kiel et al., , 2008 ; Kim et al., 2006; Yilmaz et al., 2006) . Addition of LSK markers to these SLAM family markers only modestly increases HSC purity but is useful to confirm the purity of the cells during sorting (Kiel et al., 2005 (Kiel et al., , 2008 Kim et al., 2006; Yilmaz et al., 2006) . MPPs can be isolated by selecting CD150 À CD48 À LSK cells (Kiel et al., 2008) . Consistent with this, the self-renewal and reconstituting potentials of HSCs decline as CD150 expression levels decline (Papathanasiou et al., 2009; Beerman et al., 2010; Morita et al., 2010) .
Despite markers that can give high levels of HSC and MPP purity, HSC and MPP populations remain functionally heterogeneous. Most CD150 + CD48
À LSK HSCs are in G 0 and only 3% are in S/G 2 /M phase of the cell cycle, indicating that this population contains very few cycling cells (Kiel et al., 2007) . Nonetheless, the quiescent cells in this population are heterogeneous with respect to the rate at which they enter cycle over time, with about 80% going into cycle every 12 days and about 20% of the cells entering cycle every 100 days (Wilson et al., 2008; Foudi et al., 2009) . HSCs are also heterogeneous with respect to the ratio of myeloid to lymphoid cells that they generate upon transplantation into irradiated mice (Mü ller-Sieburg et al., 2002; Dykstra et al., 2007; Kent et al., 2009; Beerman et al., 2010; Challen et al., 2010; Morita et al., 2010) and with respect to their self-renewal potential upon transplantation (Ema et al., 2005; Benveniste et al., 2010; Morita et al., 2010) . However, limitations in the ability to purify each subset of HSCs has meant that some subsets of HSCs have often been characterized based on retrospective analyses of reconstitution patterns in irradiated mice (Copley et al., 2012) .
MPPs are heterogeneous with respect to reconstitution kinetics in irradiated mice and the types of blood cells they produce (Morrison and Weissman, 1994; Morrison et al., 1997; Adolfsson et al., 2005; Yang et al., 2005; Forsberg et al., 2006) . However, many of the MPP populations that have been studied are relatively impure: many cells must be transplanted to detectably reconstitute irradiated mice. The dependence on such heterogeneous populations has confounded the ability to characterize these cells-new markers are required.
The inability to resolve distinct subpopulations of HSCs has impeded our ability to characterize their niche. HSCs reside in a perivascular niche in which endothelial cells and perivascular stromal cells promote HSC maintenance by producing SCF and Cxcl12 (Sugiyama et al., 2006; Mé ndez-Ferrer et al., 2010; Ding et al., 2012; Greenbaum et al., 2013; Ding and Morrison, 2013) . Conditional deletion of Scf or Cxcl12 from osteoblasts did not affect HSC frequency or function (Ding et al., 2012; Greenbaum et al., 2013; Ding and Morrison, 2013) . However, conditional deletion of Scf or Cxcl12 from endothelial cells or from Leptin Receptor-expressing perivascular stromal cells did deplete bone marrow HSCs. Conditional deletion of Scf from both endothelial cells and perivascular stromal cells in Tie2-Cre; Lepr-Cre; Scf fl/À mice eliminated most HSCs based on surface marker phenotype (Ding et al., 2012) . However, others have speculated that only ''activated'' HSCs reside in a perivascular niche. Without markers to distinguish ''activated'' HSCs, this idea has been impossible to directly test.
In this study, we extended our analysis of the SLAM family and found that four SLAM family markers, CD150 (Slamf1), CD48 (Slamf2), CD229 (Slamf3), and CD244 (Slamf4), subdivided adult mouse bone marrow LSK cells into seven functionally distinct fractions of cells: two that contained HSCs, three that contained MPPs, and two that contained restricted hematopoietic progenitor cells (HPCs). These fractions formed a hierarchy that exhibited progressive changes in cell-cycle kinetics, self-renewal capacity, and reconstituting potential. These markers thus allowed us to distinguish different subsets of HSCs and MPPs while prospectively isolating each population to a high degree of purity. Use of these markers, along with reconstitution assays, showed that the vast majority of phenotypically and functionally identifiable HSCs were lost when Scf was conditionally deleted from endothelial cells and perivascular stromal cells in the bone marrow of adult Tie2-Cre; Lepr-Cre; Scf fl/À mice. Quiescent HSCs therefore depend upon a perivascular niche for their maintenance. (Kiel et al., 2005 (Kiel et al., , 2008 . In the present study, we investigated the expression of CD229 (Slamf3), CD244 (Slamf4), CD84 (Slamf5), and Ly108 (Slamf6). CD84 and Ly108 were similarly expressed by almost all LSK cells (Figures 1B and 1C) . In contrast, CD229 was heterogeneously expressed by HSCs and HPC-2 cells ( Figure 1D ) and CD244 was heterogeneously expressed by HSCs, MPPs, and HPC-2 cells ( Figure 1E) . Figure S1 available online shows the expression of CD229, CD244, CD84, and Ly108 on other subpopulations of hematopoietic progenitors.
Differences in CD229 and CD244 expression subdivided CD150 + CD48 À/low LSK HSCs into two fractions and CD150 Figure 1G ).
We first analyzed the expression of markers used previously to distinguish HSCs and MPPs including CD34, Flt3 (also known as Flk2), Thy1, EPCR, and ESAM (Spangrude et al., 1988; Osawa et al., 1996; Christensen and Weissman, 2001; Adolfsson et al., 2005; Yang et al., 2005; Balazs et al., 2006; Ooi et al., 2009; Yokota et al., 2009 ). The HSC-1 population contained more CD34 À/low Flt3 À cells than HSC-2 cells, suggesting that HSC-1 cells were more primitive ( Figure S2A ). Figure S3A ). According to these markers, more than 90% of HSC-1, HSC-2, MPP-1, and MPP-2 cells were in G 0 at any one time, but significantly fewer MPP-3 cells were in G 0 (88% ± 3%), and the HPC-1 and HPC-2 fractions were actively cycling (Figures 2A-2C ). The frequencies of cells in G 1 and S/G 2 /M generally increased as cells transitioned through the HSC-2, MPP-1, MPP-2, MPP-3, HPC-1, and HPC-2 fractions (Figures 2A-2C ). The only exception was that HSC-2 cells included a slightly higher frequency of cells in S/G 2 /M (2.5% ± 1.1%) as compared to MPP-1 and MPP-2 cells (both <1%) (Figures 2A-2C ).
We next administered 5-bromo-deoxyuridine (BrdU) for 24 hr or for 7 days to mice, then analyzed each subpopulation of HSCs and MPPs. The rate of BrdU incorporation increased progressively from the HSC-1 fraction through the HPC-2 population ( Figures 2D and 2E ). HSC-1 cells were most highly quiescent, with only 3.7% ± 1.5% (mean ± SD) and 23% ± 5% BrdU+ cells after 24 hr and 7 days, respectively (Figures 2D and 2E) . The rates of BrdU incorporation into HSC-2, MPP-1, and MPP-2 cells were significantly higher. Almost all MPP-3, HPC-1, and HPC-2 cells incorporated BrdU over a 7 day period ( Figures 2D and 2E) . W  f  o  %  n  o  i  s  s  e  r  p  x  e  r  e  k  r  a  m  e  c  a  f  r  u  S  n  o  i  t  c  a  r  F HSC-1 CD150 + CD48 -/low CD229 -/low CD244 -Lineage -/low Sca-1 + c-Kit + 0.0020±0.0005 HSC-2 CD150 + CD48 -/low CD229 + CD244 -Lineage -/low Sca-1 + c-Kit + 0.0065±0.0021 MPP-1 CD150 -CD48 -/low CD229 -/low CD244 -Lineage -/low Sca-1 + c-Kit + 0.0006±0.0001 MPP-2 CD150 -CD48 -/low CD229 + CD244 -Lineage -/low Sca-1 + c-Kit + 0.0159±0.0038 MPP-3 CD150 -CD48 -/low CD229 + CD244 + Lineage -/low Sca-1 + c-Kit + 0.0237±0.0056 HPC-1 CD150 -CD48 + Lineage -/low Sca-1 + c-Kit + 0.1132±0.0271 HPC-2 CD150 + CD48 + Lineage -/low Sca-1 + c-Kit + 0.0032±0.0014 We also used histone H2B-GFP label retention to monitor the division history of HSC and MPP subpopulations (Wilson et al., 2008; Foudi et al., 2009) . The Col1A1-H2B-GFP; Rosa26-M2-rtTA double transgenic mice (Foudi et al., 2009 ) were administered doxycycline or 6 weeks to label all hematopoietic cells with H2B-GFP then chased for 6, 12, or 24 weeks without doxycycline to monitor the rate at which H2B-GFP was lost over time. Figures S3B-S3D show the gates used to distinguish GFP high from GFP low cells. After 6 weeks of chase, most HSC-1, HSC-2, MPP-1, and MPP-2 cells retained high levels of GFP but the frequency of GFP high cells decreased progressively among these populations ( Figure 2F ). In contrast, few MPP-3 cells retained high levels of GFP and the HPC-1 and HPC-2 populations lost almost all GFP high cells ( Figure 2F Figure 2G ). Our data are thus consistent with previously published results (Morrison and Weissman, 1994; Foudi et al., 2009) in indicating that many MPPs divide at similar rates as HSCs. Similar trends were observed after 24 weeks of chase, though by this time few cells in any population retained high levels of GFP ( Figure 2H ).
HSC-1 and HSC-2 Contain a Hierarchy of Long-Term Multilineage Reconstituting Cells Five HSC-1 or HSC-2 cells isolated from UBC-GFP mice were transplanted into irradiated recipient mice along with 200,000 recipient bone marrow cells. UBC-GFP donors were used to assess donor contributions to erythrocyte and platelet reconstitution, in addition to myeloid, B, and T cells (Figures S4A and S4B) . Both fractions gave long-term multilineage reconstitution in most recipients ( Figures 3A and 3B ). Ninety-three percent of recipients that received HSC-1 cells had long-term myeloid and lymphoid reconstitution by donor cells ( Figure 3C ). Fiftyfour percent of recipients that received HSC-2 cells had longterm myeloid and lymphoid reconstitution ( Figure 3C ). Another 34% of recipients of HSC-2 cells exhibited transient reconstitution by myeloid and lymphoid cells, suggesting that HSC-2 cells represent a transitional population between long-term self-renewing HSCs and transiently self-renewing MPPs. All recipients of five HSC-1 cells had donor-derived HSC-1, HSC-2, MPP-1, MPP-2, MPP-3, HPC-1, HPC-2, CMP, GMP, MEP, and CLP cells in their bone marrow ( Figure 3D ; see Figure S4C for individual mice). Consistent with our cell-cycle analysis (Figure 2 ), this suggests that HSC-1 includes the most Figures 3E and S4D) ; however, recipients of HSC-2 cells usually did not have donor-derived HSC-1 cells ( Figure S4D ). This suggests that HSC-1 cells give rise to HSC-2 cells but that HSC-2 cells have little capacity to form HSC-1 cells.
HSC-2
We also transplanted single HSC-1 or HSC-2 cells along with 200,000 bone marrow cells into irradiated mice. Fourteen of 30 mice that received one HSC-1 cell were reconstituted by donor cells 16 weeks after transplantation, and 12 of these mice exhibited long-term multilineage reconstitution, suggesting that at least 40% of HSC-1 cells are HSCs. The reconstituted recipients of HSC-1 cells exhibited high levels of donor cells at 16 weeks after transplantation (27% ± 24% of nucleated blood cells, mean ± SD), usually myeloid-biased reconstitution (Figure 3F) . Nine of 30 mice that received one HSC-2 cell were reconstituted by donor cells 16 weeks after transplantation, usually lymphoid-biased reconstitution ( Figure 3G ). Only four of these recipients were long-term multilineage reconstituted, suggesting that at least 13% of HSC-2 cells were HSCs. The reconstituted recipients of HSC-2 cells had lower levels of donor cells (13% ± 15% of blood cells, mean ± SD) than recipients of HSC-1 cells ( Figure 3G ).
Based on the criteria used to distinguish myeloid-biased, balanced, and lymphoid-balanced clones (Mü ller-Sieburg et al., 2002), 79% of HSC-1 cells were myeloid biased, 7% were balanced, and 14% were lymphoid biased ( Figure S4E ). Among HSC-2 cells, 22% were myeloid biased, 22% were balanced, and 56% were lymphoid biased ( Figure S4E ). Based on the criteria used by Dykstra et al. (2007) , the HSC-1 population contained 57% a cells, 21% b cells, 7% g cells, and 14% d cells ( Figure S4F ). The HSC-2 population contained 11% a cells, 11% b cells, 22% g cells, and 56% d cells ( Figure S4F ). SLAM family markers thus make it possible to prospectively enrich subpopulations of HSCs that were retrospectively analyzed in prior studies based on reconstitution patterns in irradiated mice.
We also transplanted five CD45. Figure 3H ). To assess self-renewal potential, we transplanted five million bone marrow cells from primary recipients that were long-term multilineage reconstituted by donor cells into irradiated secondary recipients. Bone marrow from nine recipients of five HSC-1 cells was transplanted into a total of 32 secondary recipients. Twenty-six of these 32 secondary recipients of HSC-1 cells were long-term multilineage reconstituted by donor cells (Figures 4A and 4C) . At 17 to 25 weeks after secondary transplantation, most secondary recipients had donor HSC-1, HSC-2, MPP-1, MPP-2, and MPP-3 cells as well as all of the restricted progenitor populations that we examined ( Figure 4D ). HSC-1 cells thus have long-term self-renewal potential and form all of the other stem and progenitor cell populations that we examined.
Five long-term multilineage reconstituted recipients of five HSC-2 cells were transplanted into a total of 17 surviving secondary recipients. Eight of these 17 secondary recipients were long-term multilineage reconstituted by donor cells and the other nine secondary recipients were transiently multilineage reconstituted ( Figures 4B and 4C) . The secondary recipients of HSC-2 cells that exhibited long-term multilineage reconstitution exhibited declining levels of donor myeloid cells, in contrast to secondary recipients of HSC-1 cells that usually exhibited increasing levels of donor myeloid cells over time (compare Figures 4A and 4B) . At 17 to 25 weeks after secondary transplantation, most secondary recipients of HSC-2 cells lacked donor HSC-1, HSC-2, or MPPs ( Figure 4E ). Secondary recipients of HSC-2 cells exhibited significantly lower levels of donor cell reconstitution than secondary recipients of HSC-1 cells (Figure 4F ). HSC-2 cells therefore appear to have more limited self-renewal capacity than HSC-1 cells.
The HSC-2 population can be further subdivided by CD34 expression ( Figure S2A ). Nine out of 12 recipients of five CD34 À/low HSC-2 cells were long-term multilineage reconstituted. In contrast, none of the recipients of five CD34 + HSC-2 cells were long-term multilineage reconstituted, though they showed transient multilineage or lymphoid-only reconstitution ( Figure S4G ). These data indicate that CD34 + HSC-2 cells have less HSC activity than CD34 À/low HSC-2 cells, as expected (Osawa et al., 1996) . We compared the gene expression profiles of HSC-1 and HSC-2 cells with gene sets for megakaryocyte/erythrocyte (MkE) lineage cells, granulocyte/macrophage (GM) lineage cells, lymphoid lineage cells (Må nsson et al., 2007) , and fetal liver HSCs (He et al., 2011) . The MkE gene set was significantly enriched in HSC-1 cells, whereas GM and lymphoid gene sets were significantly enriched in HSC-2 cells ( Figure S4H ). Fetal liver HSC-associated genes were significantly enriched in HSC-1 cells ( Figure S4H ). These results are consistent with our data, suggesting that HSC-1 cells are more primitive than HSC-2 cells.
MPP-1 Cells Include Intermediate and Transiently Reconstituting Progenitors
Upon competitive transplantation of five MPP-1 cells into irradiated mice, only one of ten recipients was long-term multilineage reconstituted by donor cells (Figures 5A and 5B) . Six of ten 5D ). However, the levels of myeloid reconstitution in these mice tended to decline over time ( Figure 5C ), and when we analyzed the bone marrow of these mice 17 weeks after transplantation, none of the recipients had donor-derived HSC-1 cells ( Figure 5E ). Multiple recipients had donor-derived MPP-1, MPP-2, MPP-3, HPC-1, HPC-2, as well as various restricted progenitor cells.
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HSC-2
To assess self-renewal potential, we performed secondary transplants of bone marrow cells from the primary recipients of 25 MPP-1 cells at 17 weeks after transplantation. Two primary recipients gave long-term multilineage reconstitution in the secondary recipients (1 and 5), two gave only transient multilineage reconstitution, and one gave only T lineage reconstitution (Figure 5F ). A minority of MPP-1 cells retains the ability to give long-term multilineage reconstitution, but these cells appear to have intermediate self-renewal potential and little ability to form HSC-1 or HSC-2 cells. The HSC-2 and MPP-1 populations have successively reduced reconstituting and self-renewal potentials relative to HSC-1 cells. 6C) . None of the recipients were long-term reconstituted. SLAM family markers can therefore be used to isolate a highly purified population of MPPs, from which only five cells can give transient multilineage reconstitution in most recipients, including within the erythroid and platelet lineages.
MPP-2 and MPP-3 Are Transiently Reconstituting Multipotent Progenitors
We also competitively transplanted 5 or 25 CD150
+ LSK MPP-3 cells into irradiated mice. Recipients of 25 MPP-3 cells were all transiently multilineage reconstituted, though at levels that were significantly (p < 0.01 at 4 weeks) lower than in recipients of 25 MPP-2 cells ( Figures 6B and 6C ). Myeloid chimerism in recipients of 25 MPP-3 cells also appeared to be lost earlier (4-6 weeks after transplantation) than in recipients of 25 MPP-2 cells (6-8 weeks after transplantation). Four of five recipients of 25 MPP-3 cells were also transiently reconstituted by platelets and erythrocytes ( Figures 6B and 6C ). Recipients of five MPP-3 cells exhibited transient reconstitution in the myeloid and/or B lineages ( Figures 6B and 6C ). Two to three of the recipients of five MPP-3 cells were reconstituted by donor platelets and erythrocytes ( Figures 6B and 6C) . None of the recipients were long-term reconstituted. MPP-3 cells therefore include multipotent progenitors, though these cells reconstitute more transiently and at lower levels than MPP-2 cells.
HPC-1 and HPC-2 Cells Contain a Mixture of Restricted Progenitors
Most recipients of five HPC-1 cells were not detectably reconstituted by donor cells but two were transiently reconstituted by donor B cells ( Figure 6F ). Four of five recipients of 25 HPC-1 cells were transiently reconstituted by B cells, with or without T cells (Figures 6D and 6F ). Only one of the recipients of 25 HPC-1 cells was transiently reconstituted by platelets and erythrocytes. Seven of eight recipients of 200 HPC-1 cells were transiently reconstituted by donor myeloid and B cells, four of which also had donor erythrocytes but only one of which had platelets ( Figure 6F ). These data suggest that HPC-1 cells are a heterogeneous population of restricted progenitors that includes early lymphoid progenitors as well as some cells that give very low levels of transient myeloerythroid reconstitution. The kinetics of B lineage reconstitution by HPC-1 cells is earlier than from MPP-3 cells (compare Figure 6D to 6B), suggesting that HPC-1 lymphoid progenitors are more mature than the multipotent MPP-3 cells. HPC-1 cells are therefore the first population from which multilineage reconstitution was not evident from small doses of cells and the only LSK population that rarely formed platelets. Most HPC-1 cells appeared to be restricted progenitors that lacked megakaryocytic potential.
We no donor-derived progeny from HSC-1 cells, consistent with other data indicating that this is a very primitive and quiescent population ( Figure S5B ). HSC-2 cells gave rise to low levels of donor myeloid, erythroid, megakaryocyte, and B cells, indicating that these cells are more readily activated after transplantation than HSC-1 cells ( Figure S5B ). MPP-1, MPP-2, and MPP-3 cells all tended to give higher levels of reconstitution in all lineages than HSC-2 cells, indicating that these populations are more mature than HSCs while remaining multipotent and able to form both erythrocytes and megakaryocytes ( Figure S5B ). HPC-1 cells formed primarily B cells and some myeloid cells, but few, if any, erythroid or megakaryocyte lineage cells. HPC-2 cells formed very low levels of cells in multiple lineages, including myeloid cells, B cells, and megakaryocyte lineage cells ( Figure S5B ).
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Colony Forming Potential
To investigate the clonogenic potential of individual cells in each stem and progenitor cell population without regard to whether they have sufficient reconstituting activity to be detected in vivo, we assessed colony formation in culture. As expected, 91% ± 1.2% and 96% ± 1.2% of HSC-1 and HSC-2 cells formed colonies, usually large mixed myeloid, myeloerythroid, and/or megakaryocyte colonies ( Figure 7A ). Among MPPs, 64%-72% of cells in each population formed colonies, mainly myeloid or mixed myeloerythroid and/or megakaryocyte colonies (Figure 7A) . Thus, most MPP-1, MPP-2, and MPP-3 cells had the potential to form myeloid cells and at least 10%-20% of the cells in each population were able to form erythrocytes and/or megakaryocytes. Only 24% ± 2.4% of HPC-1 cells and 37% ± 12% of HPC-2 cells formed colonies in culture ( Figure 7A) . None of the colonies contained erythrocytes or megakaryocytes. When these data are combined with the lymphoid-restricted reconstitution patterns observed from HPC-1 cells in vivo ( Figures 6D and 6F) , the data suggest that HPC-1 cells include a mixture of myeloidrestricted progenitors and lymphoid-restricted progenitors that have largely lost the potential to make erythrocytes or megakaryocytes. Alternatively, a minority of HPC-1 cells may be multipotent progenitors whose ability to reconstitute the myeloid lineage is very limited and cannot be detected from small numbers of HPC-1 cells in vivo. HPC-2 cells formed mainly small megakaryocyte colonies (5-20 cells), as well as smaller numbers of mixed myeloerythroid and/or megakaryocyte colonies (Figure 7A) , consistent with the reconstitution data observed in vivo ( Figures 6E and 6F) . Figure S7E ). We transplanted 300,000 bone marrow cells from each of these genetic backgrounds along with 300,000 recipient bone marrow cells into irradiated recipient mice. Relative to mice transplanted with wild-type control bone marrow, the levels of donor cell reconstitution were significantly reduced in mice transplanted with bone marrow from Tie2-Cre; Scf fl/À mice, Figure 7E ).
Using these data, we calculated HSC frequencies based on Poisson statistics (Smith et al., 1991 Figure S7D ). The failure of Tie2-Cre; Lepr-Cre; Scf fl/À bone marrow cells to give long-term multilineage reconstitution of any secondary recipients is consistent with the analysis of HSC-1 and HSC-2 frequencies and confirms that the vast majority of HSCs in the bone marrow, including most quiescent HSCs, depend upon a perivascular niche for their maintenance.
DISCUSSION
The CD150, CD48, CD229, and CD244 SLAM family markers are differentially expressed among LSK cells in a manner that distinguishes functionally distinct subpopulations of HSCs and MPPs ( Figures 7B and S7F ). Prior use of markers such as CD150 expression level (Morita et al., 2010) , CD34 expression (Osawa et al., 1996) , Flk2 expression (Christensen and Weissman, 2001; Yang et al., 2005) , and a2 integrin expression (Benveniste et al., 2010) distinguished functionally distinct subpopulations of HSCs and MPPs. However, many subsets of HSCs and MPPs remained heterogeneous, such that certain subpopulations were largely characterized through retrospective analysis of reconstitution patterns in irradiated mice (Copley et al., 2012) . The multiplexing of SLAM family markers distinguishes multiple subsets of HSCs and MPPs that differ in terms of reconstituting potential and other functional properties, allowing each subpopulation to be prospectively isolated to a high degree of purity. HSC-1 cells were the most quiescent ( Figure 2 ) and gave mainly myeloid-biased reconstitution ( Figures 3F, S4E , and S4F). HSC-2 cells divided more frequently and gave mainly lymphoid-biased reconstitution (Figures 2, 3G, S4E and S4F) . MPP-1 cells gave transient multilineage reconstitution, including myeloid reconstitution for up to 8 weeks after transplantation (Figures 5A-5D ). MPP-1 cells self-renewed and formed all MPP and HPC populations but never formed HSC-1 cells and almost never formed HSC-2 cells ( Figure 5E ). MPP-2 cells contained transiently reconstituting multipotent progenitors that reconstituted the myeloid lineage for up to 6 weeks after transplantation ( Figures 6A and 6C ). MPP-3 cells gave transient multilineage reconstitution, including myeloid reconstitution for up to 4 weeks after transplantation ( Figures 6B and 6C) . MPP-1, MPP-2, and MPP-3 cells all gave rise to both megakaryocytes, platelets, and erythrocytes, in vitro and in vivo, even when only five cells from these populations were transplanted into irradiated mice ( Figures 5A-5C , 6A-6C, 7A, and S5B).
The ability of Flt3 + LSK MPPs to make megakaryocytes and erythrocytes has been debated Forsberg et al., 2006; Boyer et al., 2011) . One complication is that Flt3 + LSK cells are heterogeneous and prior in vivo studies injected 50-10,000 cells into irradiated mice to test developmental potential Yang et al., 2005; Forsberg et al., 2006; Luc et al., 2008) . The inability to perform a clonal, or near clonal, analysis of developmental potential in vivo made it difficult to take into account the heterogeneity within the population. Our data indicate that SLAM family markers can resolve Flt3 + CD34 + LSK cells into a hierarchy of at least four functionally distinct subpopulations contained within the MPP-2, MPP-3, HPC-1, and HPC-2 populations ( Figure S5A ). Consistent with prior studies , most Flt3 + LSK cells were contained within the HPC-1 population (Figures S2A and S5A) and the Flt3 + subset of HPC-1 cells formed myeloid and/or B cells but not platelets or erythrocytes ( Figures  S6D and S6F) . What remains uncertain from our data is whether these Flt3 + HPC-1 cells include multipotent cells with both myeloid and lymphoid potential or a mixture of lymphoidrestricted and myeloid-restricted progenitors.
Consistent with other published studies (Forsberg et al., 2006; Boyer et al., 2011) 7E ) and these mice developed anemia upon aging (Figure S7E) . Most or all quiescent HSCs are maintained in a perivascular niche by factors secreted by endothelial and perivascular stromal cells.
EXPERIMENTAL PROCEDURES Mice
For reconstitution assays, donor cells were isolated from 8-to 12-week-old UBC-GFP mice (Schaefer et al., 2001 ) that were backcrossed at least six times onto a C57BL/Ka-CD45.2:Thy1.1 background. Recipient mice were C57BL/ Ka-CD45.1:Thy1.2, greater than 8 weeks old, unless otherwise mentioned. For cell surface marker analysis, Ki-67 and PI staining, BrdU incorporation assays, and in vitro colony formation assays, cells were obtained from C57BL/Ka-CD45.2:Thy1.1 mice. Col1A1-H2B-GFP (Foudi et al., 2009 ) and Rosa26-M2-rtTA (Hochedlinger et al., 2005 ) transgenic mice were used for H2B-GFP label retention assays. For conditional Scf deletion analysis, we crossed Scf fl mice (Ding et al., 2012) with Tie2-Cre (Koni et al., 2001) and Lepr-Cre (DeFalco et al., 2001) mice. All mice used in this study were housed in the Unit for Laboratory Animal Medicine at the University of Michigan (UM) or in the Animal Resource Center at the University of Texas Southwestern Medical Center (UTSW). All procedures were approved by the UM Committee on the Use and Care of Animals and by the UTSW Institutional Animal Care and Use Committee.
Flow Cytometry
Bone marrow cells were flushed from tibias and femurs using Hank's balanced salt solution (HBSS, Invitrogen) without calcium or magnesium, supplemented with 1% head-inactivated calf serum (GIBCO). When we flushed bones, we drilled a hole in the intact bone using a needle and did not clip off the epiphyses. Bone marrow cells were sometimes obtained by crushing tibias, femurs, pelvic bones, and vertebrae with a mortar and pestle. Both methods gave indistinguishable results. Cells were gently triturated and filtered through a nylon screen (45 mm, Sefar America) to obtain a single-cell suspension. Lineage markers were anti-CD2, anti-CD3ε, anti-CD5, anti-CD8a, anti-B220, anti-Gr-1, and anti-Ter119. Anti-CD41 was included in the lineage cocktail when staining HSCs from young adult mice, but not from older mice (such as in the niche experiments) due to the increase in CD41 expression by HSCs with age. In older mice, CD41 was stained separately to exclude CD41 high megakaryocyte lineage cells.
Bone marrow cells were incubated with biotinylated antibodies against lineage markers, followed by anti-biotin microbeads, and Lineage + cells were depleted by autoMACS (Miltenyi Biotec). The fraction enriched for Lineage À/low cells was further incubated with phycoetythrin (PE)-Cy7-conjugated anti-CD150 antibody, fluorescein isothiocyanate (FITC)-conjugated anti-CD48, allophycocyanin (APC)-conjugated anti-CD229, PE-conjugated anti-CD244, Alexa Fluor 700-conjugated anti-Sca-1, APC-eFluor 780-conjugated anti-c-Kit, and streptavidin PE-Texas Red. Dead cells were excluded by staining with 4', 6-diamidino-2-phenylindole (DAPI, Sigma). All antibodies are listed in Table S1 .
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